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For the decade after its initial description by Cramiak 
and coworkers 0.2). contrast echocardiography was used 
largely for stmctUre identification, detection of intracardiac 
shunts and valvular regurgitation and in the diagnosis of 
more complex congenital heart disease (3). There has re- 
cently been widespread interest in the use of contrat 
eLhocardiagraphy for myocardial perfusion imaging (413). 
and within the past few years intracaronary injections of 
echo contrast agents have been used in humans for this 
purpose (1417). 
Preliminary studies have suggested that echacardio- 
graphic wntrast agenta may be associated with transient 
myocardial depression (IS.%ZO), and that the presence of 
microbubbles may be predominantly responsible for this 
adverse ffect (21.22). Orher studies ( 17.23) have reported no 
measurable additional myocardial depression due to micro- 
bubbles. This finding is of potential clinical import because 
ronicated contrast agents are being used in human studies in 
many institutions. The purpose of this study, therefore. was 
to funber examine the potemial negative effects of intraw 
ronary microbubbles on mechanical left ventricular function 
in an open chest canine model by assessing myocardial 
thickening and segmental wall motion with the use of dif- 
ferent doses and different sizes of microbubbles. 
Methods 
Experimental preparation. Nine mongrel dogs 120 to 28 
ke) were anesthetized with inwavenous thiamyld (16 to 20 
n&g body weigh& their trachea intubated and their lungs 
ventilated with n Harvard volume respirator. Alpha- 
chloralose (30 to 60 mg) was administered intravenously as 
needed for maintenance of anesthesia. The electrocardio- 
gram (ECG) and femoral artery pressure were monitored 
thmuahout the experiment. T% dogs were placed in the 
right lateral decubitns position and their chest opened by left 
lateral thoracotomy through the fourth intercostal space. 
The pericardium WBE incised and used as a cradle support for 
the exposed heart. The left carotid artery and proximal left 
anterior descending coronary anety were dissected. After 
systemic heparinization (IO.003 U intravenously) and pro- 
phylactic adminwntion of intravenous lidacaine (SO.mg 
b&s). a plastic cannula was inserted shunting blood from 
the carotid artery to the left anterior dosceadicg coronary 
artery. The distal carotid anery and proximal anterior de- 
scending artery were occluded, so the entire left carotid flow 
was channeled to the coronary nnery and the entire anterior 
descending artery Row came fmm the carotid shunt. The 
shunt had a side pan permitting access for repeated injec- 
tions, with continued perfusion of the anterior descending 
artery by blood through the shunt between iniections. 
Reparatiw of son&d microbubhks. A-model W-375 
Sonicatar IHeat Svstems-Ultrasonics Inc.) with a OS in. 
(1.27 cm) titanium&ped horn was used &generate micro- 
bubbles. The energy control wns set betwe& 4 and 6 and 
tuning was routinely done to aswre optimal operation at the 
highest efficiency. Two different sire spectra microbubble 
suspensions were gettented by sonicating 8 ml of Renogra- 
tin.76 (meglumine sodium diatrizoate) contained in n IO ml 
plastic syringe with the use of two different methods of 
sonication. In the first method the tip of the horn was placed 
0.25 in. (0.63 cm) under the surface of the solution and fixed 
with a clamp. The duration of sonication depended on the 
occurrence of opacification and ranged fmm 20 to 30 s. In the 
second method the smicator horn was placed I cm below 
the surface of the Renogratin, and sonic&m was performed 
for 30 s at the specified settings with two brief periods at IO 
and 20 s, respectively, of lowering the syringe so that the 
sonicator tip was immediately below the surface. This 
method of sonic&ion has been previously described (17). 
Mkrobubbkanalysls. Immediitely after contrast pmduc- 
lion, I drop of the solution, sampled from the middle of the 
syringe. was placed on a microscope slide with a cover slip. 
Microbubble size was detemtined with a hemacytometer by 
viewing multiple fields at x40 magnification. Twenty-five 
microbubbles were measured from each sonication run. The 
microbubble eoncentration (number of microbubbles per 
high power field) was determined by counting the number of 
microbubbler in four adjacent fields. For each method of 
sonication, eight samples were obtained with the USC of a 
fresh solution of Renografin.76 each time. The mean and SD 
of the microbubble size and concenwation were calculated. 
~hocsrdiogruphieex.minstion. The dogs were placed in 
the right lateral decubitus position on a specially built table 
with a central opening. Twodimensional images were oh- 
trained with a Toshiba SSH-40 instrument. A 5 MHz trans- 
ducer held by P. clamp was positioned below the closed right 
hemithorax at the point of maximal cardiac impulse. The 
transducer wns positioned to continuously tmaie the left 
ventricle in a short-axis view nt the mid-papillary muscle 
level. This position and angle were maintained throughout 
the study, The gain settings were adjusted at the beginning of 
each study and maintained unchanged throughout the study. 
All echocardiographic images were recorded on videotape 
for subsequent analysis. Baseline recordings were obtained. 
Thereafie;. recordings were started approximately IO s 
before each iniection and continued for 30 s or until contraxt 
enhancement &td regional wall motion abnormalities, when 
present, were no longer evident. 
Intracnronary rnntrast injections. Repeated intracom- 
nary injections~were made of micmhubbles of the two 
different size spectra. To determine if the presence of 
transient left ventricular depression was related to the micro. 
bubble content rather than to the contrast agent itself, 
control injections were made of nonsonicated Renogratin. 
Also. normal saline solution was injected as a control. For 
each of the two microbubble size suspensions and for the 
cantml injections of nonsonicated Renografn and saline 
solution, 0.5, I, 2 and 3 ml doses were -injected into the 
carotid-comnnry artery shunt and Rushed into the tnyocar- 
dinm by the natural forward pulsatile arterial blood flow in 
the line. All intracoronary injections were made in rnndotn 
order and separated by 25 min from the prior injection or 
from disappearance of contrast or resolution of wall motion 
abnormalities. 
&hnwdinwsnhic data analvsis. All iniections were 
identified on tie kdeorecording only by the-kjection num- 
ber, thus allowing for subsequent blinded analysis. Video- 
tapes were analyzed by an experienced observer (F.X.) 
using acommercially available Microsonics DataVue off-line 
analysis system. This digital image analysis systemconsisted 
of an IBM AT micmnrocessor and n hieb-weed digitizer 
converting the analog’video signal into digiti farm. icho- 
cardiographic frames were selected by the operator, who 
played the videotape in slow motion and then froze the 
desired image on the screen. Measurements were made of 
percent depression of systolic wall thickening, duration of 
wall motion abnormalities. peak contrast enhancement and 
contrast washout. 
Systolic wall Ihkkening. After depth calibration, mea- 
surements were made of wall thickening by selecting end- 
diastolic and end-systolic frames for analysis. All measure- 
ments were ECG.gated. The end-diastolic frame selected 
was the one demonstruting the largest left ventr~ular wrface 
urea and corresponded to the onset of the Q ~v,avc The 
end-systolic frame selected was the one demonstrating rhe 
smallesr left ventricular surface area. For each m~ecr~on. 
measurements were made of wall thickening @VT) at base- 
line and at maximal endocardial wall motion abnormality and 
computed as the mean of three consecutive beats. 
~SWT = End-systolic WI - End-dia\tolic WT x ,w, 
0 
End-diastolic WT 
Baseline WSWT - tnject lrSW7 x ,w 
Baseline %SWT 
where “inject %SWT” is the percent systolic wall rhicken- 
ing measured at maxinxl subjective depresston of thicken- 
ing When no depression was apparent, measurements wre 
made at maximal subjective contrast enhancement or. in the 
absence oi myocnrdial opacification, at 5 s after injection, 
Duration of wall motion abnormalities was defined as the 
time taken for endocardial wall motion to return to baseline 
level. 
Analysis cd enntnwt effect. Peak contrast intensity was 
quantitated by videcdensitometry with the use of a software 
package for videodensity analysis. A region of interest was 
designated by the operafar in the area of the myocardium 
with maximal contrast enhancement by choosing a 10 x 10 
pixel rectangular area. The sofiware then gave the minimal, 
maximal and average values of videodensity bused on 256 
units of gray scale level. The average videodensity per pixel 
level within the area of interest was chosen as the-va&ble 
studied. The position and size of the region of interest were 
kept constant throughout the analysis of each injection to 
eliminate effects of attenuation and ditliaction. For each 
injection, baseline level of videodensity and the peak value 
obtained during myocardial ccmtrast opcification were re- 
corded. Subsequently, videodenrity was measured every 5 s 
until the disappearance of contrast. Baseline pixel values 
were subtracted from values obtained after injection of the 
contraa~t agent. Adequate myccardial contrast enhancement 
was defined when the videodensity per pixel level exceeded 
2 SD of the control level recorded at baseline. Duration of 
contrast enhancement (contrast washout) was defined as the 
time taken for myocardial contrast to return to the baseline 
level. 
Slalislkal utalysis. Analysis of variance was carried out 
to assets the effects ofvolume (0.5, I, 2 and 3 ml) and agents 
tested (saline solution, nonsonicated Renogratin and I2 and 
20 arm bubbles in Renografm) on percent depression of 
systolic wall thickening. duration of regional wall motion 
abnomuditieo, peak contrast enhancement and contrast 
washout. When significant F ratios were observed, ditTer- 
ences among rhe groups were identified by the paired Stu- 
dent’s r test with the Bcmferroni correcuon. Correlation 
between duration of regional wall motion abnormalities and 
contrast washout time ‘$2~ done by linear regression analy- 
sis. Data are presented as mean 2 I SEM. Statistical 
significance wzs defined asp < 0.05. 
Results 
In vitmdatts. The micmbubbles genernted with the use of 
the first method of sonication had a mean diameter of 20 t 6 
pm with a concentration of 29 r 9 microbubbles per high 
power field. The second method of sonic&m produced 
smaller and more unifwm microbubbles with a mean diam- 
eter of I2 f 3 sm and a concentration of 24 c 7. The 
difference in the concentration of microbubbles obtained 
with the two methods of sonicatiw was statisticallv rianifi- _ 
cant (p = 0.02). 
Animal results. We could obtain comolete data in only 
five of nine dogs studied. One dog died of ventricular 
fibrillation due to dotting of the carotidaxonary shunt, one 
dog had an infarct resulting from dislodgment of the cow 
rnary cannula and in two dogs the quality of echocardic- 
gmphic or contrast images was not satisfactory for analysis. 
A total of nine complete sets of data were obtained from the 
remaining five dogs. Each complete set of data included I6 
injections (four doses x four agents), resulting in I44 echo- 
cardiographic recordings that were analyzed as the basis for 
this repon. 
Systolic wall thkktniug. As compared with preinjection 
levels, significant depression in systolic wall thickening 
occurred with intrucoronary injections of both I2 anti 20 w 
bubbles in Renogmfirt at all four doses tested. Significant 
depression in wall thickening was also seen with injections of 
Fire 2. Duration of regional wall r&on abnormalities (‘#MA) 
during intracoronary mjectionr of different voIumes and echo con- 
trast agcnlr. Sonicated Renografin and large bubble size and doses 
caused a longer duration of regkanal wall motion abnormalities 
compared with nunsanicated Renogmfin. Saline solution did not 
cause signifxanl wall motion abnormalities. Symbols as in Figure 1. 
I. 2 and 3 ml ofnonsonicated Renografm. Saline solutionand 
0.5 ml of Renografin alone did not cause any significant 
depression of regional contractility. Figure I illustrates the 
effects of the different doses and agents on percent deprcs- 
sion in wall thickeomg. Larger doses caused signiticanrly (p 
< O.OOI) greater depression in regional contractility (9.8 z 
1.8, 18.5 -c 3.3.31.7 + 5.5and42.2? 5.2for0.5, 1.2and3 
ml. respectively). The extent of wall motion abnormalities 
was also related to the agent injected. There were significant 
differences among the arcctcst dcoresskm of wall thickcnina 
seen with the Is&r mi&bubblc~(48. I 2 5). the depression 
seen with the smaller microbubbles (33.0 + 7.9, II. < O.C011 
and the lesser degree of depression of wall thickening seen 
with nonsonicated Renografin (p < 0.05 versus the smaller 
microbubbles). Nonsonicated Rcnografm caused signifi- 
cnntlv more desrcssion of thickeninc than did control iniec- 
lions of saline solution (17. I 2 4.9 versus 3.9 i 3.7, p < 
0.01). Maximal percent dcoression in wall thickenine 04.3 + 
6.9) was seen with injeciion of 3 ml of 20 &m ‘b;bblcs. 
Transient dyskinesia was only noted with some injections of 
the largest dose of the 20 pm bubbles. Wall thickening wilhin 
nonenhanced zones showed no sipnificant change with con- 
trast injections. 
Duration of wall motion abnormalities. All changes in 
regional contractility were transient and normalized, on the 
average, at 12 s (range 3 to 521 after contrast agent injection. 
FigUrC 2 shows the relation between dose and agent injected 
and the duration of regional wall motion abnormalities. The 
longest duration was seen with the 20 pm bubbles as 
compared with the I2 pm bubbles (18.1 + 2.0 versus 10.3 i- 
1.6. p < 0.001). There were also significanl diffcrcnces 
between the duration of wall motion abnormalities observed 
after injections of I2 pm bubbles versus nonsonicated Re- 
no@in (10.3 2 I .6 vcrs”s 5.2 2 I. I, p c. 0.05) and between 
nonsonicated Rcnograiin compared with saline solution (5.2 
Figure 3. Peak videodensity with intrccorcmary injections of normal 
saline solurion (NSI and Renogr& (RG). A significant increase in 
eonwart eRcc, is seen with sonicated Reeograhn. Little further 
increase in contrast enhancement occurred with the larger micro. 
bubbles and doses. Values represent mean peak. videodensity sub- 
tracted from baseline videodensny. MB-12 = 12 pm bubbles: MB-20 
= 20 rm bubbles. Solid ban = 0.5 ml; thickly hatched bars = I ml; 
dolled bars = 2 ml; lightly hatched bars = 3 ml. 
? 1.1 versus 0.4 f 0. I, p < 0.001). An increasingduration of 
wall nwtion abnormalities was also abservcd with iniections 
of increasing doses of the contrast agent (p < O.oO& 
Contrast tnhsttccmcnt. Figure 3 depicts the effects of the 
ditTercnt agent3 and doses injected on peak videodensity. All 
a~cnts. with the exceaion of saline solution and 0.5 and I ml 
n&onicatcd Renog&n. produced adequate contrast en- 
hancement. Sonication me& imwwed Desk contrast in- 
tensity (22.1 * 2.1 v&us j0.l -+ 3.2 ior nonsanicated 
Renografm versus I2 ,um bubbles in Rcnogralin. p c 0.001). 
The 20 run bubbles caused further impmvement in contrast 
c5cct (62.0 t 2.8. D < 0.01 versus the I2 um bubbles). The 
effect if larger dos;s of contrast agent an kak vid&&nsity 
was not statistically significant. 
Cantcart washout. Peak cwtrast effect wxrrrd within 5 
s of each iqjection of the contrast agent. The contrast cleared 
gradually and none remained by an average of 22 s (range 5 
to 70). Figure 4 shows the duration of contrast washout in 
relation to bath dose and agent injected. A greater delay in 
contrast washout was seen with the larger doses (p c 0.01). 
SiEnificant differences in washout time were found between 
ZO-and I2 I” bubbles (36.7 + 2.9 versus 18.8 i 1.6. p < 
OJJOI) and between 12 pro bubbles and nonsonicatcd Rcno- 
@in (18.8 i I.6 vcrs;s 9.8 + 1.5, p < 0.001). There was a 
significant (p < 0.001) correlation between the duration of 
wall motion abnomtalhies and wntrast clearance time (r = 
0.93). 
Figwe 5 shows nn aurn& of~rrch dose and agent e,crs 
on sysysrolic wall rhickeninp. Lrulion of wall mo!iZm &or- 
mu/ides, conlrasl enhoncrmwzt and CORWUUS~ washout. It 
represents end-systolic frames of two-dimensional cchocar- 
diagrams acquired during irriection of 3 ml of 20 urn bubbles 
in Rcnografm (upper and middle panels) and 0.5 ml of 12 pm 
bubbles in Renografin (lower panel) into the ante&r de- 
scending coronary artery The left ventricle is visualized in a 
short-axis view at the level of the papillary musclc. Both 
injections produced optimal myocardial opacification of the 
anteriordescendingartery perfusion bed (blackarrows) with 
a clear demarcation between contrast-enhanced and nonen- 
hanced regions. The 20 pm bubbles caused local wall motion 
abwrmalities (white arrow, uoper uaucl) that normalized 
gradually with washout of &‘con&t. No wall motion 
abnornmlities were seen at the lower dose of 12 am bubbles. 
D&y of contrast washout occurred with 20 ;rn bubbles 
whereas complete clearance ol contrast is \een within 10 s 
aiter injection ol I2 pm bubbles. 
Discussion 
Intracoronary hjcnions of echocardiographic ontrast 
agents are being used in humans to assess myocardial 
p&ion l!4-17.24-28). Sonicatiw has been advocated 8s a 
method to produce small, stable microbubbles that can utt~s 
through th,: microcirculation without obstruction. Ho&r, 
published wnication protocols do not ensure the production 
of microbubMes maller than capdlary diameter and. though 
mean we ofmicrobubbles may be smaller than the capillary 
diameter. only a small proportion of larger micmbubbles 
would be sufficient to block capillaries and cauce “hangup.” 
Our IWO sonication protocols are bath consistent with pre- 
viously published protocols and neither insure against cap 
illary ~Iuecmr! and transient microbubble-related ventricular 
deprerrion. 
EiTects on left vent&drir funetinn. Our results support 
previous studies (I&21) that have reported transient de- 
crease in regional mycardial function after intracoronary or
intraaortic root injections of echocsrdiographic contrast 
agents. Our results differ from those of Lang et al. (17.23) in 
that we noted transient effects that appear to be a conse- 
quence of the properties of both the carrier soIu!ion and the 
presence of microbubbles. The difference in the obxrved 
results may be related to the smaller microbubble sia (IO fr 
4 pm) reported by Lang et al. with the use of a sir&r 
Figsrc 5. Stilt frames howing end-systolic frames from 
echaesrdiogmms acquired during contrast injections 
into the left anterior descending coronary artery of 1 ml 
of Ramgain with 20 ,on bubbles (upper sd ndddk 
pa&) and 0.5 ml of Renografin with I2 +m bubMcs 
(bwr WA,. Black arrows = areus of mwcardial 
contrasi. White wrow = area of transient endcardial 
waUmotionabnormality. See textforfurtherdetails. EL 
= baseline; ivs = int&enrricularseptum; P = papillary 
IIIUsFI.5. 
sonic&m protocol. It is possible that minor variations in 
sonic&on technique may explain the small difference in 
microbubble size achieved by Lang et al. compared with our 
investigation. 
Contrast cnhsncement and washo,,,. In this study. there 
was adequae contrast effect (defined as a videodensity per 
pixel level exceeding two times the standard deviation of the 
control recording1 wi,h injections of 2 or 3 ml of nonsonica- 
ted Renogmtin-76. The mechanism for this contrast effect is 
not clear. It IS possible that microbubbles may have been 
generated. A contrast effect with nonsonicated contrast 
media has been previously described by Yasui et al. (29) who 
recorded two-dimensional echocardiograms during coronary 
arteriography in 10 patients. In six of the patients. the echo 
intensity of the interventricular septum increased during left 
coronary arteriogmphy and in four of eight patientr the echo 
intensily of the lef, venlricular posterior wall increased 
during right coronary ancriograpby. 
Sonicorion grcorly inrrensed the comras~ inrcnsiry of rhe 
resulrinp imopcs. Our data indicate that both large and small 
microbubbles at a11 iour doses tested produced good contrast 
enhancement. Although peak videodensity was greate, with 
the larger bubbles, this difference is probably not clinically 
significant (Fig. 5). This minimal increase in co~tmst effect 
was obtained a, the expense of a substantial increase in 
transient lefi ventricular depression. 
II has been hypothesized that the conrros~ echo d&p 
pesrrrnr~ rorc should represent on index of regionni myo- 
cordial perfusion (13). Tei et al. (30) used hand-agitated 
saline-Rcnogratin solution to correlate myocardial echo can- 
tras, disappcamnce rate against the severity of experimental 
coronary slenosis. A limitation of their study was that 
physiologic transit time was not attained, implying the 
oecurrcenec of capillary plugging. Our results suppon their 
hypothesis that micmbubblc size plays a significant role in 
eon,rast washout kinetics and that more prolonged disap- 
pearance rate is seen with solutions containing the larger 
microbubbles. Other st?ldies 13 l-33) of mvocardial Derfusion 
by eontras, echocardiography ha& loiked at peak echo 
contrast intensity as a wtential index of mvocardial c&u- 
sion and have found variable corrclation~ with coronary 
blood flow. Our study shows that both micmbuhbk size and 
dose delivered arc &nifieant factors affecting echocardio- 
graphic contrast enhancement. 
Although the differences in concentration of microbub- 
bles obtained with each method of sonic&m was small (29 
2 9 versus 24 ? 7 per high power field), this ditfercnce was 
statistically significant (p = 0.02). It is possible that a 
concentration effect may be responsible for some of the 
differences observed between the large and small microbub- 
bier. 
Conclusions. Microbubbles contribute to the transient 
left ventricular depression of sonicated Renografin. Larger 
microbubblc size and larger doses of microbubbles add to 
lefl ventricular depression. Adequate contrast enhancement 
las measured by videodensi,ome,ry) occurs with the smaller 
microbubbles and doses studied. Physicians performing 
myocardial perfusion imaging with the USI fcontrast echo- 
cardiography should be aware of this potential toxicity and 
strive for the smallest microbubhle size and dose necessary 
to attain adequate contrast. Further, measurements of re- 
gional myocardial blood flow with the use of contrast echo- 
cardiography may be akcted bv bubble size and dose if 
there is “hangup” of contrast. 
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